GSTP1 rs1695 polymorphism, oxidative stress markers, and antioxidants in coronary artery disease
Keywords:
oxidative stress markers, antioxidants, coronary artery diseaseAbstract
Oxidative damage is among the essential factors in the progression of cardiovascular disease. Objectives: This study aims to evaluate the molecular role of GST genotypic polymorphism involved in the development of CAD. This study also aimed to compare the levels of oxidative stress and antioxidant markers in subjects with CAD with age and sex-matched controls. Result: There was no significant difference in allele frequency (p= 0.85) or genotype frequency (p= 0.85) between the examined case and control groups. Compared to healthy controls, F2-Isoprostanes and MDA levels were considerably elevated in individuals with coronary artery disease. CAD patients' GST, SOD, Vitamine E, and Vitamin C levels were considerably lower than in normal control subjects. Conclusion: This study observed that oxidative stress markers were significantly higher, whereas, in CAD patients, enzymatic and nonenzymatic-enzymatic antioxidants were significantly lower. This study could not find a good connection between GSTP1 gene polymorphism rs1695 and coronary artery disease.
Downloads
References
Ayala, A., Muñoz, M. F., & Argüelles, S. (2014). Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative medicine and cellular longevity, 2014.
Banerjee, M., & Vats, P. (2014). Reactive metabolites and antioxidant gene polymorphisms in type 2 diabetes mellitus. Redox biology, 2, 170-177.
Bastani, A., Rajabi, S., Daliran, A., Saadat, H., & Karimi-Busheri, F. (2018). Oxidant and antioxidant status in coronary artery disease. Biomedical Reports, 9(4), 327-332.
Bhat, M. A., Mahajan, N., & Gandhi, G. (2012). Oxidative stress status in coronary artery disease patients. Int J Life Sc Bt Pharm Res, 1, 236-243.
Davies, S. S., & Roberts II, L. J. (2011). F2-isoprostanes as an indicator and risk factor for coronary heart disease. Free Radical Biology and Medicine, 50(5), 559-566.
Hajar, R. (2017). Risk factors for coronary artery disease: historical perspectives. Heart views: the official journal of the Gulf Heart Association, 18(3), 109.
Kadiiska, M. B., Gladen, B. C., Baird, D. D., Germolec, D., Graham, L. B., Parker, C. E., ... & Barrett, J. C. (2005). Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?. Free Radical Biology and Medicine, 38(6), 698-710.
Lobo, V., Patil, A., Phatak, A., & Chandra, N. (2010). Free radicals, antioxidants, and functional foods: Impact on human health: Pharmacognosy Reviews, 4(8), 118.
Ninić, A., Bogavac-Stanojević, N., Sopić, M., Munjas, J., Kotur-Stevuljević, J., Miljković, M., ... & Spasojević-Kalimanovska, V. (2019). Superoxide dismutase isoenzymes gene expression in peripheral blood mononuclear cells in patients with coronary artery disease. Journal of Medical Biochemistry, 38(3), 284.
Pencina, M. J., Navar, A. M., Wojdyla, D., Sanchez, R. J., Khan, I., Elassal, J., ... & Sniderman, A. D. (2019). We are quantifying the importance of significant risk factors for coronary heart disease. Circulation, 139(13), 1603-1611.
Pourkeramati, A., Mehrjardi, E. Z., Tezerjani, M. D., & Seifati, S. M. (2020). Association of GSTP1, GSTT1, and GSTM1 gene variants with coronary artery disease in Iranian population: a Case-Control Study. International Journal of General Medicine, 13, 249.
Reszka, E., Jabłonowski, Z., Wieczorek, E., Gromadzińska, J., Sosnowski, M., & Wąsowicz, W. (2011). GSTP1 mRNA expression in human circulating blood leukocytes is associated with GSTP1 genetic polymorphism. Clinical biochemistry, 44(13), 1153-1155.
Torkzaban, A., Naeini, A. A., Hassanzadeh, A., & Namdari, M. (2020). A case-control study is a relationship between serum vitamin C and uric acid levels, antioxidant status, and coronary artery disease: clinical nutrition research, 9(4), 307.
Zhang, Z. J. (2013). A systematic review on the association between F2-isoprostanes and cardiovascular disease. Annals of Clinical Biochemistry, 50(2), 108-114.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
